Lv31
354 积分 2024-09-06 加入
Pathogenesis and Systemic treatment of Hepatocellular Carcinoma: Current Status and Prospects
5小时前
已完结
Mechanisms of adaptive resistance to targeted therapy in RET-aberrant cancers
1个月前
已完结
YAP regulates HER3 signaling-driven adaptive resistance to RET inhibitors in RET-aberrant cancer
1个月前
已完结
STAT5 activation enhances adoptive therapy combined with peptide vaccination by preventing PD-1 inhibition
2个月前
已完结
A novel designed anti-PD-L1/OX40 bispecific antibody augments both peripheral and tumor-associated immune responses for boosting anti-tumor immunity
2个月前
已完结
Complete remissions of HER2-positive trastuzumab-resistant xenografts using a potent [225Ac]Ac-labeled anti-HER2 antibody-drug radioconjugate
2个月前
已完结
Targeting EZH2 for cancer therapy: From current progress to novel strategies
2个月前
已完结
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
2个月前
已完结
EZH2 function in immune cell development
2个月前
已完结
Intra- and Extrahepatic Cholangiocarcinomas Display Differing Sensitivities to NK Cell Lysis and Modulate NK Cell Function Through Shared and Distinct Pathways
2个月前
已完结
皖公网安备34019202002308
